Christine Solbach

10.1k total citations · 2 hit papers
140 papers, 5.3k citations indexed

About

Christine Solbach is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Christine Solbach has authored 140 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 61 papers in Cancer Research and 32 papers in Molecular Biology. Recurrent topics in Christine Solbach's work include Breast Cancer Treatment Studies (52 papers), HER2/EGFR in Cancer Research (31 papers) and Cancer Treatment and Pharmacology (19 papers). Christine Solbach is often cited by papers focused on Breast Cancer Treatment Studies (52 papers), HER2/EGFR in Cancer Research (31 papers) and Cancer Treatment and Pharmacology (19 papers). Christine Solbach collaborates with scholars based in Germany, United States and Switzerland. Christine Solbach's co-authors include Sibylle Loibl, Gϋnter von Minckwitz, Knut Engels, Manfred Kaufmann, Carsten Denkert, Claus Hanusch, Thomas Karn, Uwe Holtrich, Marc Roller and Achim Rody and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Christine Solbach

130 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

2009 1.3k citations Carsten Denkert, Sibylle Loibl et al. Journal of Clinical Oncology profile →
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

2022 136 citations Sibylle Loibl, Andreas Schneeweiß et al. profile →

Peers

Countries citing papers authored by Christine Solbach

Since Specialization

Citations

This map shows the geographic impact of Christine Solbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Solbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Solbach more than expected).

Fields of papers citing papers by Christine Solbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Solbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Solbach. The network helps show where Christine Solbach may publish in the future.

Co-authorship network of co-authors of Christine Solbach

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Solbach. A scholar is included among the top collaborators of Christine Solbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Solbach. Christine Solbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	B-cell lymphoma 6 in breast cancer: molecular mechanisms and clinical significance 2025 ·Critical Reviews in Biochemistry and Molecular Biology ·Frank Louwen, Andreas Ritter, Nina‐Naomi Kreis, (unknown), Christine Solbach, Juping Yuan	0
2	KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker 2024 ·Critical Reviews in Clinical Laboratory Sciences ·Nina‐Naomi Kreis, (unknown), Linda Wordeman, Frank Louwen, Christine Solbach, Juping Yuan, Andreas Ritter	5
3	On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer 2024 ·Breast Cancer Research ·Bruno V. Sinn, (unknown), M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, Wolfgang Schmitt, Frederik Marmé, Christian Schem, Christine Solbach, Elmar Stickeler, Hans Tesch, Peter A. Fasching, Andreas Schneeweiß, Volkmar Müller, Johannes Holtschmidt, Valentina Nekljudova, Sibylle Loibl, Carsten Denkert	1
4	Cancer-educated mammary adipose tissue-derived stromal/stem cells in obesity and breast cancer: spatial regulation and function 2023 ·Journal of Experimental & Clinical Cancer Research ·Andreas Ritter, Nina‐Naomi Kreis, Susanne Roth, Alexandra Friemel, (unknown), (unknown), (unknown), (unknown), Frank Louwen, Christine Solbach, Juping Yuan	26
5	RNA expression levels from peripheral immune cells, a minimally invasive liquid biopsy source to predict response to therapy, survival and immune-related adverse events in patients with triple negative breast cancer enrolled in the GeparNuevo trial. 2023 ·Journal of Clinical Oncology ·Hanna Huebner, Matthias Rübner, Andreas Schneeweiß, Carsten Denkert, Hans‐Peter Sinn, Michael Braun, Thomas Karn, Bruno V. Sinn, Dirk M. Zahm, Jörg Thomalla, Jens Huober, Claus Hanusch, Michael Untch, Christine Solbach, Theresa Link, Natalie Filmann, Julia Rey, Sibylle Loibl, Peter A. Fasching	1
6	The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy 2023 ·Breast Cancer Research ·Pauline Wimberger, Jens‐Uwe Blohmer, Petra Krabisch, Theresa Link, Marianne Just, Bruno V. Sinn, Eike Simon, Christine Solbach, Tanja Fehm, Carsten Denkert, (unknown), Kerstin Rhiem, Hans Tesch, Sherko Kümmel, (unknown), Oliver Stötzer, (unknown), Jan Dominik Kuhlmann, Valentina Nekljudova, Sibylle Loibl	6
7	Human placental mesenchymal stromal cells are ciliated and their ciliation is compromised in preeclampsia 2022 ·BMC Medicine ·(unknown), Nina‐Naomi Kreis, Alexandra Friemel, Susanne Roth, (unknown), (unknown), (unknown), Thorsten Nowak, Christine Solbach, Frank Louwen, Andreas Ritter, Juping Yuan	13
8	Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Obesity and the Tumor Microenvironment of Breast Cancer 2022 ·Cancers ·Andreas Ritter, Nina‐Naomi Kreis, (unknown), Christine Solbach, Frank Louwen, Juping Yuan	43
9	Mitotic Centromere-Associated Kinesin (MCAK/KIF2C) Regulates Cell Migration and Invasion by Modulating Microtubule Dynamics and Focal Adhesion Turnover 2021 ·Cancers ·(unknown), Nina‐Naomi Kreis, Alexandra Friemel, Susanne Roth, Dorothea Schulte, Christine Solbach, Frank Louwen, Juping Yuan, Andreas Ritter	26
10	The Function of Oncogene B-Cell Lymphoma 6 in the Regulation of the Migration and Invasion of Trophoblastic Cells 2020 ·International Journal of Molecular Sciences ·Andreas Ritter, (unknown), (unknown), Nina‐Naomi Kreis, Alexandra Friemel, Susanne Roth, Christine Solbach, Frank Louwen, Juping Yuan	9
11	Restoration of primary cilia in obese adipose-derived mesenchymal stem cells by inhibiting Aurora A or extracellular signal-regulated kinase 2019 ·Stem Cell Research & Therapy ·Andreas Ritter, Nina‐Naomi Kreis, Susanne Roth, Alexandra Friemel, Lukas Jennewein, (unknown), Christine Solbach, Frank Louwen, Juping Yuan	25
12	Subcutaneous and Visceral Adipose-Derived Mesenchymal Stem Cells: Commonality and Diversity 2019 ·Cells ·Andreas Ritter, Alexandra Friemel, Susanne Roth, Nina‐Naomi Kreis, (unknown), (unknown), (unknown), (unknown), Christine Solbach, Frank Louwen, Juping Yuan	49
13	Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases 2019 ·Journal of Experimental & Clinical Cancer Research ·Simon Bernatz, Elena I. Ilina, Kavi Devraj, Patrick N. Harter, (unknown), Sascha Kleber, Yannick Braun, (unknown), Christoph Renner, Rashi Halder, Lukas Jennewein, Christine Solbach, Frits Thorsen, Bernhard C. Pestalozzi, Axel Mischo, Michel Mittelbronn	13
14	Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44) 2018 ·Journal of Clinical Oncology ·Michael Untch, Gϋnter von Minckwitz, Bernd Gerber, Christian Schem, Mahdi Rezai, Peter A. Fasching, Hans Tesch, Holm Eggemann, Claus Hanusch, Jens Huober, Christine Solbach, Christian Jackisch, Georg Kunz, Jens‐Uwe Blohmer, Maik Hauschild, Tanja Fehm, Valentina Nekljudova, Sibylle Loibl, (unknown)	40
15	Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients 2012 ·BMC Cancer ·Wulf Siggelkow, Daniel Boehm, Susanne Gebhard, Marco Johannes Battista, (unknown), Antje Lebrecht, Christine Solbach, Birte Hellwig, Jörg Rahnenführer, Heinz Koelbl, Mathias Gehrmann, Rosemarie Marchan, Cristina Cadenas, Jan G. Hengstler, Marcus Schmidt	45
16	Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation 2011 ·European Journal of Cancer ·Thomas Karn, Lajos Pusztai, Eugen Ruckhäberle, Cornelia Liedtke, Volkmar Müller, Marcus Schmidt, Dirk Metzler, Jing Wang, Kevin R. Coombes, R. Gätje, Lars Hanker, Christine Solbach, A. Ahr, Uwe Holtrich, Achim Rody, Manfred Kaufmann	39
17	T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers 2009 ·Breast Cancer Research ·Achim Rody, Uwe Holtrich, L. Pusztai, Cornelia Liedtke, R. Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, A. Ahr, Dirk Metzler, Knut Engels, Thomas Karn, Manfred Kaufmann	336
18	Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1 2007 ·Clinical Cancer Research ·Achim Rody, Uwe Holtrich, R. Gaetje, Mathias Gehrmann, Knut Engels, Gϋnter von Minckwitz, Sibylle Loibl, (unknown), Eugen Ruckhäberle, Dirk Metzler, A. Ahr, Christine Solbach, Thomas Karn, Manfred Kaufmann	54
19	Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions 2005 ·Endocrine Related Cancer ·Achim Rody, Uwe Holtrich, Christine Solbach, (unknown), G von Minckwitz, Knut Engels, Stefan Kissler, R. Gätje, Thomas Karn, M. Kaufmann	65
20	Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study. 1994 ·PubMed ·Tobias Goeser, Hans‐Michael Müller, Christine Solbach, K. Gmelin, (unknown), B Kommerell, Lorenz Theilmann	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact